Programme

Tuesday, April 26, 2005
9.30 am

Opening Ceremony

Welcoming words

Juha-Matti Savola, Chairman of the Finnish Bioindustries, Juvantia Pharma Ltd

Opening Words

Paavo Lipponen, Speaker of the Parliament of Finland
Leena Peltonen-Palotie, University of Helsinki and National Public Health Institute
G. Steven Burrill, Burrill & Company

Investor Forum

Moderator: Mike Ward, Critical I

11.00 am

Investor Forum Welcome Remarks

Pauli Marttila, Executive Director, Sitra

11.10 am

Investor Forum Opening Lecture: State of the Industry (Download PDF, 3 MB)

G. Steven Burrill, CEO, Burrill & Company

12.00 pm

Company presentations

  • Biotie Therapies Corp.
  • Quattromed Ltd
  • Juvantia Pharma Oy Ltd
  • CTT Cancer Targeting Technologies Oy
1.00 pm

Break

2.00 pm

Key Note: Creating Business Models for Success

Nigel Parker, CEO, Ark Therapeutics Group plc

2.20 pm

Company presentations

  • FIT Biotech Oyj Plc
  • Celecure AS
  • Karyon Ltd
  • GeneOS Group
3.10 pm

Coffee break

3.30 pm -
5.00 pm

Panel Discussion: Strengths and Weaknesses in European Biotech Businesses

Panel: G. Steven Burrill, Burrill & Company
Nigel Parker, Ark Therapeutics
Neil D. Cook, PerkinElmer Corporation (Cancelled)
Yann Bonduelle, PWC Corporate Finance
Matthias Ledig, Capgemini
Moderator: Mike Ward, Critical I

6.00 pm -
7.00 pm

Reception at the Helsinki City Hall

By the courtesy of the City of Helsinki

Wednesday April 27, 2005

Investor Forum

Moderator: Mike Ward, Critical I

10.30 am

Opening remarks

Kalevi Kurkijärvi, Chairman and CEO, BioFund Management Ltd

10.40 am

Pipeline Valuations

Yann Bonduelle , Head of UK Valuation and Strategy, PWC Corporate Finance

11.00 am

Company presentations

  • Mobidiag Oy Ltd
  • Labmaster Ltd
  • SiMEMS Pte Ltd
  • Orgenium Laboratories Oy Ltd
11.50 pm

Break

12.20 pm

Key Note: Diagnostics—a Changing Market

Neil D. Cook, Vice President, R&D and CSO, PerkinElmer Corporation (Cancelled)

12.40 pm

Company presentations

  • Jurilab Ltd
  • Galilaeus Oy
  • Medipolis GMP Oy Ltd
  • BCB Medical Ltd
1.30 pm

Key Note: Financial Strategy of a European Biotech Company

Thierry Jean, CEO Cerep

1.50 pm

Panel Discussion: Winning Biotech Business Models

Panel: Thierry Jean, CEO Cerep
Nigel Parker, Ark Therapeutics
Neil D. Cook, PerkinElmer Corporation (Cancelled)
Yann Bonduelle, PWC Corporate Finance
Martin Godbout, Genome Canada
Moderator: Mike Ward, Critical I

3.00 pm -
3.30 pm

Coffee and networking

Top of page